EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Chitosan‐Based Nanoparticles for Twist1 Knockdown in 4T1 Cells

Asim Mushtaq iD, Li Li iD, Anitha A iD, Lisbeth Grøndahl iD

Macromolecular Bioscience · 2025

DOI: 10.1002/mabi.202400627 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Macromolecular Bioscience, 2025. Verfasst von Asim Mushtaq und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Molecular Biosciences, The University of Queensland, Cooper Road, Brisbane, Queensland, 4072, Australia. Hauptthemen laut MEDLINE: Twist-Related Protein 1, Chitosan, Nanoparticles, RNA, Small Interfering. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Queensland, Australia, National Health and Medical Research Council, Australian Centre for HIV and Hepatitis Virology Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bone metastasized breast cancer reduces the quality of life and median survival. Targeted delivery of twist1‐siRNA using nanoparticles (NPs) is a promising strategy to overcome current limitations in treating such metastatic breast cancers. This research evaluates two types of chitosan (CHI)‐based NPs for the delivery of twist1‐siRNA. Alendronate conjugated PEG functionalized chitosan (ALD‐PEG‐CHI) NPs are developed for active targeting while PEG functionalized CHI (mPEG‐CHI) NPs are fabricated for passive targeting. The size of twist1‐siRNA‐loaded NPs is below 70 nm and the zeta potential is near neutral for both types of NPs. Based on gel retardation assay, complete encapsulation of twist1‐siRNA is achieved in both NP systems. The ALD‐PEG‐CHI‐siRNA and mPEG‐CHI‐siRNA NPs display serum protection for 6 and 4 h, respectively, compared to the immediate degradation of naked twist1‐siRNA. The NPs can knockdown twist1 in 4T1 cells as demonstrated through protein expression as well as by phenotypic change in directional cell migration by wound healing assay. Overall, these in vitro results illustrate the potential of the NPs as an effective therapeutic system for bone metastasized breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Twist-Related Protein 1ChitosanNanoparticlesRNA, Small InterferingNuclear ProteinsGene Knockdown TechniquesBreast NeoplasmsCell Line, TumorAnimalsFemaleMiceHumansCell MovementPolyethylene GlycolsAlendronate

Stichwörter der Autor:innen

SiRNA deliverychitosannanomedicinepoly(ethylene glycol)twist1

Substanzen

Twist-Related Protein 1ChitosanRNA, Small InterferingNuclear ProteinsTwist1 protein, mousePolyethylene GlycolsTWIST1 protein, humanAlendronate

Autor:innen und Institutionen

  • School of Chemistry and Molecular Biosciences, The University of Queensland, Cooper Road, Brisbane, Queensland, 4072, Australia.
  • Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Corner of College and Cooper Road, Brisbane, Queensland, 4072, Australia.

ORCID-Profile: Asim Mushtaq, Li Li, Anitha A, Lisbeth Grøndahl

Förderung

  • University of Queensland, Australia
  • National Health and Medical Research Council
  • Australian Centre for HIV and Hepatitis Virology Research

Zitieren

APA

Mushtaq, A., Li, L., A, A., & Grøndahl, L. (2025). Chitosan‐Based Nanoparticles for Twist1 Knockdown in 4T1 Cells. Macromolecular Bioscience. https://doi.org/10.1002/mabi.202400627

Vancouver

Mushtaq A, Li L, A A, Grøndahl L. Chitosan‐Based Nanoparticles for Twist1 Knockdown in 4T1 Cells. Macromolecular Bioscience. 2025. doi:10.1002/mabi.202400627

BibTeX
@article{Mushtaq2025,
  author = {Mushtaq, Asim and Li, Li and A, Anitha and Grøndahl, Lisbeth},
  title = {Chitosan‐Based Nanoparticles for Twist1 Knockdown in 4T1 Cells},
  journal = {Macromolecular Bioscience},
  year = {2025},
  doi = {10.1002/mabi.202400627}
}
Kostenlos starten →